AI analyzes funding data you can't access anywhere else
Our proprietary AI monitors 15,000+ companies and identifies which funded companies need YOUR specific solution right now.
Amalgam Rx, Inc. announced it raised $650,000 in an initial filing from an offering of $750,000
Amount Raised
$650,000
Round Type
seed
WilmingtonHealthcareCompany Information
Location
1007 N. MARKET STREET
Wilmington, Delaware, United States
About
Amalgam helps patients and providers make the best decisions possible - in the provider workflow and in patients’ everyday lives. Through a suite of EHR Solutions and a modular SaMD platform Amalgam enables the leading life sciences companies, health plans, and provider organizations to collaboratively deliver better care. Today, Amalgam's algorithms and applications support nearly 10 million patients across 4 continents and have helped providers make over 50 million decisions. For more information on how Amalgam's regulated digital products, EHR solutions, or 10 billion RWE data points can help your organization engage patients and providers, visit amalgamrx.com.
Company News
(8 articles)Amalgam Rx™ Enhances Partnership with Novo Nordisk® - Business Wire
Amalgam’s Generative AI Platform Wins Coveted 2024 AI Breakthrough Awards - GlobeNewswire
Otsuka Precision Health, Amalgam Rx unveil app for Alzheimer's caregivers - Mobi Health News
Amalgam Rx™ and Novo Nordisk® Plan Global Expansion - Business Wire
iSage Rx Presents Positive Clinical Outcomes from Initial Study - GlobeNewswire
Otsuka Precision Health, Inc. (OPH) and Amalgam Rx Announce the Digital Support Solution for Caregivers Supporting Patients with Alzheimer’s Disease - ChannelBiz UK -
Privia Health Leverages Amalgam Rx’s EHR-Integrated Solutions to Personalize Care - Business Wire
Amalgam Rx Named to the 2022 CB Insights’ Digital Health 150 List - Business Wire
FundzWatch™ Score
Related People
Sign in to view contact details
Sign in to view contact details